Chainlink, Plexos и EDinheiro поддержат бразильскую социальную блокчейн-валюту

cryptonews.ruPublicado em 2025-05-30Última atualização em 2025-07-31

Chainlink присоединилась к институту Plexos и платформе EDinheiro в проекте по расширению финансового доступа в Бразилии через локально выпускаемые социальные валюты на базе блокчейна. Партнеры будут работать в г. Индиароба, штат Сержипи и запустят валюту Aratu. Aratu будут пользоваться около 18 000 местных жителей, которые зарабатывают на жизнь сбором моллюсков и не имеют доступа к финансовым услугам.

Социальные валюты выпускаются муниципальными или общественными банками и используются для локальных платежей и распределения помощи. Платформа EDinheiro, уже поддерживающая более 180 таких валют по всей Бразилии, будет отвечать за выпуск и управление Aratu. Технология Chainlink обеспечит безопасные связи между локальными информационными системами и блокчейн-инфраструктурой, позволяя автоматизировать отчетность, аудит и соответствие требованиям законодательства о защите данных в Бразилии.

Проект является официальным примером применения в рамках Blockchain Brazil Network (RBB) государственной инфраструктуры, созданной Федеральной Счетной палатой и Национальным банком развития. Цель RBB — повысить прозрачность и эффективность государственных программ. Институт Plexos является ассоциированным участником сети и валидатором.

Благодаря технологиям безопасности и подключения от Chainlink партнеры рассчитывают сделать социальные валюты более прозрачными и удобными в управлении. Инициатива в Индиаробе должна стать моделью для аналогичных программ в других регионах, помогая местным властям эффективно распределять помощь и стимулировать экономическую активность в малообеспеченных сообществах.

Изображение: Freepik

Criptomoedas em alta

Leituras Relacionadas

Haiwei Huaxin's Official Seal Seized by Over a Hundred People, High-Stakes Corporate Battle's 'Nuclear Deterrence' in Action Again

On August 18th, Haowei Huaxin, a semiconductor firm specializing in gallium arsenide and gallium nitride wafers, reported that over a hundred individuals forcibly entered its offices and seized the company's official seals from a safe, including the corporate, contract, and party committee seals. The incident is the latest escalation in a protracted control dispute. Haowei Huaxin, established in 2010, was originally a joint venture. Control became contested after 2021 when Zhenwei Financial Holding injected capital, becoming the largest shareholder (34.01%), while former parent Haite High-Tech's stake was diluted to 33.79%. An agreed-upon governance structure collapsed, leading to mutual accusations. Haite claimed it was locked out of the subsidiary's premises, while also alleging improper management like livestock being kept on the chip fabrication site. After state-owned Qingdao Haiyue Holdings took over Zhenwei's stake in 2023, Haite accused it of illegally seizing control. Despite Haite winning several legal battles in 2024-2026, which affirmed its rights to nominate directors and the chairman, it failed to regain physical control or recover the seals. The stakes are high: market valuations for Haite's stake in Haowei Huaxin are estimated between 3.7 to 5 billion USD, yet it is only valued at about 83 million USD on Haite's books. Losing control effectively jeopardizes a significant portion of Haite's value. In response to the seal seizure, Haite framed it as a "shareholder rights protection" action agreed upon by five shareholders. This mirrors a pattern in Chinese corporate disputes where seizing physical seals becomes a tactic to paralyze the opponent's daily operations, seen in past conflicts at companies like Dangdang and Bitmain. However, such actions don't resolve underlying ownership issues; the opposing party can report the seals stolen, declare them void, and apply for new ones, albeit with significant delay. The incident underscores how fragile corporate governance can devolve into physical confrontations over symbols of authority, with control ultimately determined by law and shareholding, not possession of a seal.

marsbitHá 24m

Haiwei Huaxin's Official Seal Seized by Over a Hundred People, High-Stakes Corporate Battle's 'Nuclear Deterrence' in Action Again

marsbitHá 24m

Bernstein Interprets MRNA's 177% Surge: What's Fundamentals and What's Hype?

Bernstein's analysis of Moderna's 177% stock surge following positive Phase 3 results for its individualized neoantigen therapy (INT) in melanoma distinguishes fundamental drivers from market speculation. The clinical breakthrough is real: the INTerpath-001 trial met its primary and key secondary endpoints, providing crucial validation for mRNA technology in oncology beyond infectious diseases. However, Bernstein argues the magnitude of the stock move cannot be justified by this single trial's fundamentals alone. The surge was amplified by three key factors: 1) A re-rating of Moderna's mRNA platform potential for expansion into other cancers, 2) A massive short squeeze, given ~15% of shares were sold short pre-announcement, and 3) The compelling "cancer vaccine" narrative that fueled broader investor enthusiasm. While the melanoma success is significant, Bernstein cautions that replication in lung, kidney, and bladder cancers—which have different immunogenicity—is not guaranteed. Furthermore, INT's commercial model faces challenges: it's a personalized treatment, not a mass-market vaccine, implying higher production costs and potential margin pressures despite a projected multi-billion dollar peak sales opportunity. The report also notes sector rotation, with some funds moving from crowded AI/semiconductor trades into defensive healthcare stocks, adding further momentum. In conclusion, Bernstein maintains a "Market-Perform" rating and a $45 price target, far below the post-surge price. It views the current valuation as pricing in an optimistic multi-cancer platform success and efficient commercialization that are yet to be proven. The clinical inflection point is clear, but the earnings inflection point awaits validation across future trials and commercial execution.

marsbitHá 24m

Bernstein Interprets MRNA's 177% Surge: What's Fundamentals and What's Hype?

marsbitHá 24m

Trading

Spot

Artigos em Destaque

Como comprar LINK

Bem-vindo à HTX.com!Tornámos a compra de ChainLink (LINK) simples e conveniente.Segue o nosso guia passo a passo para iniciar a tua jornada no mundo das criptos.Passo 1: cria a tua conta HTXUtiliza o teu e-mail ou número de telefone para te inscreveres numa conta gratuita na HTX.Desfruta de um processo de inscrição sem complicações e desbloqueia todas as funcionalidades.Obter a minha contaPasso 2: vai para Comprar Cripto e escolhe o teu método de pagamentoCartão de crédito/débito: usa o teu visa ou mastercard para comprar ChainLink (LINK) instantaneamente.Saldo: usa os fundos da tua conta HTX para transacionar sem problemas.Terceiros: adicionamos métodos de pagamento populares, como Google Pay e Apple Pay, para aumentar a conveniência.P2P: transaciona diretamente com outros utilizadores na HTX.Mercado de balcão (OTC): oferecemos serviços personalizados e taxas de câmbio competitivas para os traders.Passo 3: armazena teu ChainLink (LINK)Depois de comprar o teu ChainLink (LINK), armazena-o na tua conta HTX.Alternativamente, podes enviá-lo para outro lugar através de transferência blockchain ou usá-lo para transacionar outras criptomoedas.Passo 4: transaciona ChainLink (LINK)Transaciona facilmente ChainLink (LINK) no mercado à vista da HTX.Acede simplesmente à tua conta, seleciona o teu par de trading, executa as tuas transações e monitoriza em tempo real.Oferecemos uma experiência de fácil utilização tanto para principiantes como para traders experientes.

1.2k Visualizações TotaisPublicado em {updateTime}Atualizado em 2026.06.02

Como comprar LINK

Discussões

Bem-vindo à Comunidade HTX. Aqui, pode manter-se informado sobre os mais recentes desenvolvimentos da plataforma e obter acesso a análises profissionais de mercado. As opiniões dos utilizadores sobre o preço de LINK (LINK) são apresentadas abaixo.

活动图片